Blood Cancers

Our Key Services

• Bone Marrow Aspirate, Imprints and tissue biopsies with special stains
• Flow Cytometry
  • Acute Leukemia Basic lineage Panel
  • AML characterization panel
  • ALL Characterization panel
  • Acute Leukemia Comprehensive Diagnostic Panels
  • CLL screening Panel
  • CLL Diagnostic Panel
  • MRD panels
  • Multiple Myeloma Panel
  • MDS panel etc
• Bone Marrow Karyotyping
• FISH tests
  • CML (BCR-ABL)
  • CLL (Chr 13q, Trisomy 12, 17p.53, 11q (ATM))
  • AML (AML1-ETO, Trisomy 8, MLL, Inv(16), BCR ABL)
  • MM (Chr 13q, 17p53, 11q(ATM), IgH, FGFR3/IgH)
  • MDS (Del5q, Del 7q) etc
• Molecular tests
  • JAK2 Gene (V617F) Mutation
  • FLT3 (ITD, D835Y) Mutation
  • BCR-ABL1 Major Quantitative
  • BCR-ABL1 Major, BCR-ABL1 Minor Qualitative
  • BCR-ABL1 Minor Quantitative BCR/ABL Variant Panel (Mbcr-b2a2, b3a2, b2a3, b3a3; mbcr-e1a2, e1a3; µbcr)
  • PML/RARA Qualitative and Quantitative
  • RUNX1-RUNX1T1 (AML1-ETO) t(8;21)
  • CBFB-MYH11 inv(16)
  • TEL/AML1 MLL t(4;11)(q21;q23)
  • E2A t(1;19)(q23;p13)
  • ALL PCR Panel (BCR/ABL t(9;22)(q34;q11), TEL/AML1 t(12;21)(p13;q22), MLL t(4;11)(q21;q23), E2A t(1;19)(q21;q23))
  • Acute Leukemia Mini Panel (AML/ETO, inv(16), PML/RARA, BCR/ABL t(9;22)(q34;q11), TEL/AML1 t(12;21)(p13;q22), MLL t(4;11)(q21;q23), E2A t(1;19)(q21;q23)
  • AML PCR Panel (AML/ETO, inv(16), PML/RARA)
  • BCR/ABL1 Kinase Domain Mutation Myeloproliferative Leukemia Mutation Screening
  • MPL Mutation (MPL - S505N; W515L)
  • JAK 2 Mutation Detection Panel (Exons 12-15)
  • CEBPA Full gene sequencing
  • NPM1 Mutation Analysis (Exon 12 insertion)
  • CALR Mutation Analysis (Deletion or Insertion in Exon 9)
  • Chronic Neutrophilic Leukemia (CNL)(CSF3R Exon 14 & 17; SETBP gene)
  • GATA2 full length gene sequencing
  • c-KIT Mutation Screening (Exons 9, 11, 13, 17) etc.
• Oncomine Panels
• USG/CT guided FNAC’s to stage many lymphomas and myelomas